after stopping semaglutide In the original clinical trials looking at (the GLP-1 in Novo Nordisk's Ozempic and Wegovy) and tirzepatide (in Eli Lilly's Mounjaro and Zepbound), patients gained back most of the weight Vitality Health

This is in line with data from Wharton et al

If you are beginning your journey with semaglutide GLP-1a medication often prescribed for type 2 diabetes and weight managementyou may be curious about what changes to expect in your first month

Instead, document the condition, contact your pharmacy immediately, and store the product in your refrigerator while awaiting guidance

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Karakousis N., Kostakopoulos N.A., Georgakopoulou V.E., Pyrgioti E.E., Georgakopoulos P.N., Karakousis N.D., Pyrgioti E., Georgakopoulos P

The FDA approved semaglutide in 2021 for chronic weight management

Future Directions Tirzepatide represents just the beginning of multi-agonist approaches